VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,466 | -53.4% | 85,756 | -28.9% | 0.00% | -100.0% |
| Q2 2023 | $794,576 | -2.1% | 120,573 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $811,962 | -5.2% | 119,582 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $856,663 | +2.8% | 115,922 | +37.5% | 0.00% | 0.0% |
| Q3 2022 | $833,220 | -6.0% | 84,334 | +3.7% | 0.00% | -50.0% |
| Q2 2022 | $886,000 | -3.6% | 81,336 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $919,000 | -12.2% | 81,235 | +21.7% | 0.00% | 0.0% |
| Q4 2021 | $1,047,000 | -5.7% | 66,743 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $1,110,000 | -18.7% | 64,754 | +2.0% | 0.00% | -33.3% |
| Q2 2021 | $1,365,000 | +41.0% | 63,469 | -1.5% | 0.00% | +50.0% |
| Q1 2021 | $968,000 | +34.1% | 64,417 | +17.2% | 0.00% | +100.0% |
| Q4 2020 | $722,000 | +77.4% | 54,983 | +30.5% | 0.00% | 0.0% |
| Q3 2020 | $407,000 | -16.6% | 42,143 | -1.1% | 0.00% | 0.0% |
| Q2 2020 | $488,000 | -6.9% | 42,623 | -15.7% | 0.00% | 0.0% |
| Q1 2020 | $524,000 | -26.8% | 50,584 | +16.0% | 0.00% | 0.0% |
| Q4 2019 | $716,000 | +31.9% | 43,609 | +6.7% | 0.00% | 0.0% |
| Q3 2019 | $543,000 | -6.1% | 40,887 | -0.4% | 0.00% | 0.0% |
| Q2 2019 | $578,000 | -22.2% | 41,044 | +1.6% | 0.00% | -50.0% |
| Q1 2019 | $743,000 | +31.3% | 40,406 | +86.6% | 0.00% | +100.0% |
| Q4 2018 | $566,000 | +19.7% | 21,654 | +5.1% | 0.00% | 0.0% |
| Q3 2018 | $473,000 | +20.7% | 20,594 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $392,000 | +15.6% | 20,594 | +2.4% | 0.00% | 0.0% |
| Q1 2018 | $339,000 | +10.8% | 20,118 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $306,000 | -15.0% | 20,118 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $360,000 | +9.8% | 20,118 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $328,000 | +51.2% | 20,118 | +29.7% | 0.00% | – |
| Q1 2017 | $217,000 | -12.1% | 15,513 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $247,000 | -21.1% | 15,513 | -17.6% | 0.00% | 0.0% |
| Q3 2016 | $313,000 | +48.3% | 18,817 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $211,000 | +34.4% | 18,817 | 0.0% | 0.00% | – |
| Q1 2016 | $157,000 | -10.3% | 18,817 | 0.0% | 0.00% | – |
| Q4 2015 | $175,000 | -17.5% | 18,817 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $212,000 | -30.0% | 18,817 | -21.3% | 0.00% | 0.0% |
| Q2 2015 | $303,000 | +36.5% | 23,897 | 0.0% | 0.00% | – |
| Q1 2015 | $222,000 | -35.1% | 23,897 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $342,000 | +37.9% | 23,897 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $248,000 | -35.9% | 23,897 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $387,000 | -7.6% | 23,897 | -7.4% | 0.00% | 0.0% |
| Q1 2014 | $419,000 | +30.9% | 25,795 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $320,000 | +13.1% | 25,795 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $283,000 | +36.1% | 25,795 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $208,000 | – | 25,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |